Effect of endotoxin in IL-1β-deficient mice

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 291-296

  Fantuzzi, Giamila ^a,e   Zheng, Hui ^b   Faggioni, Raffaella ^c   Benigni, Fabio ^c   Ghezzi, Pietro ^c   Sipe, Jean D ^d   Shaw, Alan R ^b   Dinarello, Charles A ^a,e  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; INTERLEUKIN 1BETA;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANOREXIA; ARTICLE; DRUG EFFECT; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNE RESPONSE; IMMUNOGLOBULIN DEFICIENCY; IMMUNOGLOBULIN PRODUCTION; INFLAMMATORY CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANIMALS; BLOOD GLUCOSE; CELLS, CULTURED; CORTICOSTERONE; CYTOKINES; FEMALE; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1; LETHAL DOSE 50; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; SERUM AMYLOID A PROTEIN;

EID: 0030008326     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Dinarello, C. A., T. Ikejima, S. J. Warner, S. F. Orencole, G. Lonnemann, J. G. Cannon, and P. Libby. 1987. Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J. Immunol. 139:1902.
2. Ikejima, T., S. Okusawa, P. Ghezzi, J. W. M. van der Meer, and C. A. Dinarello. 1990. Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and circulating TNF-like activity in rabbits. J. Infect. Dis. 162:215.
3. Shalaby, M. R., A. Waage, L. Aarden, and T. Espevik. 1989. Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo. Clin. Immunol. Immunopathol. 53:488.
4. Cannon, J. G., R. G. Tompkins, J. A. Gelfand, H. R. Michie, G. G. Stanford, J. W. M. van der Meer, S. Endres, G. Lonnemann, J. Corsetti, B. Chemow, D. W. Wilmore, S. M. Wolff, and C. A. Dinarello. 1990. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J. Infect. Dis. 161:79.
5. Granowitz, E. V., E. Vannier, D. D. Poutsiaka, and C. A. Dinarello. 1992. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis. II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes. Blood 79:2364.
6. Dinarello, C. A. 1996. Biological basis for interleukin-1 in disease. Blood 87: 2095.
7. Alexander, H. R., G. M. Doherty, C. M. Buresh, D. J. Venzon, and J. A. Norton. 1991. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J. Exp. Med. 173:1029.
8. Henricson, B. E., R. Neta, and S. N. Vogel. 1991. An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance. Infect. Immun. 59:1188.
9. Klir, J. J., J. L. McClellan, and M. J. Kluger. 1994. Interleukin-1β causes the increase in anterior hypothalamic interleukin-6 during LPS-induced fever in rats. Am. J. Physiol. 266:R1845.
10. Geiger, T., H. Towbin, A. Cosenti-Vargas, O. Zingel, J. Arnold, C. Rordorf, M. Glatt, and K. Vosbeck. 1993. Neutralization of interleukin- 1β activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associate acute-phase response. Clin. Exp. Rheumatol. 11:515.
11. van der Berg, W. B., L. A. Joosten, M. Helsen, and F. A. van de Loo. 1994. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 95:237.
12. Karkar, A. M., Y. Koshino, S. J. Cashman, A. C. Dash, J. Bonnefoy, A. Meager, and A. J. Rees. 1992. Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS-enhancing injury in nephrotoxic nephritis in rats. Clin. Exp. Immunol. 90:312.
13. Perretti, M., E. Solito, and L. Parente. 1992. Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice. Agents Actions 35:71.
14. Cozzolino, F., A. Rubartelli, D. Aldinucci, R. Sitia, M. Torcia, A. Shaw, and R. Di Guglielmo. 1989. Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells. Proc. Natl. Acad. Sci. USA 86:2369.
15. Zheng, H., D. Fletcher, W. Kozak, M. Jiang, K. Hofmann, C. A. Conn, D. Soszynski, C. Grabiec, M. E. Trumbauer, A. Shaw, M. J. Kostura, K. Stevens, H. Rosen, R. J. North, H. Y. Chen, M. J. Tocci, M. J. Kluger, and L. H. T. Van der Ploeg. 1995. Resistance to fever induction and impaired acute-phase response in interleukin-1β deficient mice. Immunity 3:9.
16. Haley, T. J., and W. G. McCormick. 1957. Pharmacological effects produced by intracerebral injection of drugs in the conscious mice. Br. J. Pharmacol. 12:12.
17. Freudenberg, M. A., and C. Galanos. 1988. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect. Immun. 56:1352.
18. Faggioni, R., G. Fantuzzi, P. Villa, W. Buurman, L. J. H. van Tits, and P. Ghezzi. 1995. Independent down-regulation of central and peripheral tumor necrosis factor production as a result of lipopolysaccharide tolerance in mice. Infect. Immun. 63:1473.
19. Sipe, J. D., W. A. Gonnerman, L. D. Loose, G. Knapschaefer, W. J. Xie, and C. Franzblau. 1989. Direct binding enzyme-linked immunosorbent assay (ELISA) for serum amyloid A (SAA). J. Immunol. Methods 125:125.
20. Granowitz, E. V., R. Porat, J. W. Mier, S. F. Orencole, M. V. Callahan, J. G. Cannon, E. A. Lynch, K. Ye, D. D. Poutsiaka, E. Vannier, L. Shapiro, J. P. Pribble, D. M. Stiles, M. A. Catalano, S. M. Wolff, and C. A. Dinarello. 1993. Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans. Blood 82: 2985.
21. Van Zee, K. J., S. M. Coyle, S. E. Calvano, H. S. A. Oldenburg, D. M. Stiles, J. Pribble, M. A. Catalano, L. L. Moldawer, and S. F. Lowry. 1995. Influence of IL-1 receptor blockade on the human response to endotoxemia. J. Immunol. 154: 1499.
22. Lonnemann, G., G. Engler-Blum, G. Muller, K. Koch, and C. A. Dinarello. 1995. Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts. Kidney Int. 47:845.
23. Kuida, K., J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S.-S. Su, and R. A. Flavell. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267:2000.
24. Li, P., H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Jonhston, J. McDowell, M. Paskind, L. Rodman, J. Salfeld, E. Towne, D. Tracey, S. Warwell, F.-Y. Wei, W. Wong, R. Kamen, and T. Seshadri. 1995. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80:401.
25. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkemagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798.
26. Fattori, E., M. Cappelletti, P. Costa, C. Sellitto, L. Cantoni, M. Carelli, R. Faggioni, G. Fantuzzi, P. Ghezzi, and V. Poli. 1994. Defective inflammatory response in interleukin-6 deficient mice. J. Exp. Med. 180:1243.
27. Olsson, I., T. Galanaga, U. Gullberg, M. Lantz, and G. Granger. 1993. Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy. Eur. Cytokine Netw. 4:1.
28. Kozak, W., H. Zheng, C. A. Conn, D. Soszynski, L. H. T. Van der Ploeg, and M. J. Kluger. 1995. Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1β deficient mice. Am. J. Physiol. 269:R969.
29. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeman, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.
30. Car, B. D., V. M. Eng, B. Schnyder, L. Ozmen, S. Huang, P. Gallay, D. Heumantt, M. Aguet, and B. Ryffel. 1994. Interferon-γ receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179:1437.
31. Garcia, I., Y. Miyazaki, K. Araki, M. Araki, R. Lucas, G. E. Grau, G. Milon, Y. Belkaid, C. Monixi, W. Lesslauer, and P. Vassalli. 1995. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J. Immunol. 25:2401.
32. Dunn, A. 1992. The role of interleukin-1 and tumor necrosis factor alpha in the neurochemical and neuroendocrine responses to endotoxin. Brain Res. Bull. 29: 807.
33. Ebisui, O., J. Fukata, N. Murakami, H. Kobayashi, H. Segawa, S. Muro, I. Hanaoka, Y. Naito, Y. Masui, Y. Ohmoto, H. Imura, and K. Nakao. 1994. Effect of IL-1 receptor antagonist and antiserum to TNF-α on LPS-induced plasma ACTH and corticosterone rise in rats. Am. J. Physiol. 266.E986.
34. Rivier, C., R. Chizzonite, and W. Vale. 1989. In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology 125:2800.
35. Fantuzzi, G., R. Faggioni, M. Sironi, P. Ghezzi, J. D. Sipe, H. Zheng, L. H. T. van der Ploeg, A. R. Shaw, and C. A. Dinarello. 1995. Reduced inflammatory response and cytokine synthesis in interleukin-1β-deficient mice. Cytokine 7:608 (Abstract).